D615L vs Zeiss 839MP: Visual Quality
Key facts
- Who runs it
- Shanghai 10th People's Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 90 people enrolled
- Started
- 1 Apr 2025
- Expected to end
- 31 Dec 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Trifocal IOL
- Record updated
- 6 May 2026
Who can take part
- Age
- 50 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- diagnosed age-related cataract
- preoperative corneal astigmatism <1.0 D
- endothelial cell count >2000/mm²
- signed informed consent and ability to complete 6-month follow-up
Who cannot take part
- prior corneal refractive, glaucoma or vitreoretinal surgery
- uncontrolled systemic disease such as diabetes or autoimmune disorders
- intraoperative posterior capsule rupture, zonular dehiscence or vitreous loss
- corneal pathology, macular edema or optic neuropathy affecting visual assessment
- active ocular inflammation, glaucoma, maculopathy or diabetic retinopathy
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this prospective cohort study is to compare visual quality after cataract surgery in patients implanted with a new domestic trifocal intraocular lens (D615L) versus the Zeiss AT LISA tri 839MP. The main question it aims to answer is: Is the uncorrected distance, intermediate, and near visual acuity achieved with D615L non-inferior or superior to that achieved with the Zeiss 839MP? Participants diagnosed with age-related cataract will undergo phacoemulsification and receive one of the two intraocular lenses. They will attend follow-up visits where uncorrected visual acuity, defocus curves, and the VF-14 questionnaire will be assessed over a follow-up period of at least 6 months.
The 2 groups in the trial
- D615L
implanted D615L IOL
Treatment: Trifocal IOL
- 839MP
implanted 839MP IOL
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Comparative Study on Postoperative Visual Quality: New Domestic Trifocal IOL (D615L) Versus Zeiss AT LISA Tri 839MP
- Record updated
- 6 May 2026